Cancer Family
Neoplasm
CI-CAN-00000001Explore in graph →
Non-malignant22,961 active trials259 approved drugs4,031 evidence items
Loading cancer entity…
Cancer Family
CI-CAN-00000001Explore in graph →
Clinical trials
105,853 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT02275702 | Randomized Study of Preoperative Dexamethasone for Quality of Recovery in VATS Lung Resection Patients(APV) | completed | Phase 4 | 100 | Laval UniversityOTHER | 1 | Aug 25, 2021 | clinicaltrials |
| NCT01191541 | Cytarabine (Ara-C) in Children With Acute Promyelocytic Leukemia (APL)(Ara-C) | completed | Phase 4 | 65 | Xiaofan ZhuUNKNOWN | 1 | Aug 10, 2021 | clinicaltrials |
| NCT02812992 | Geriatric Assessment Directed Trial to Evaluate Gemcitabine +/- Nab-paclitaxel in Elderly Pancreatic Cancer Patients(GrantPax) | completed | Phase 4 | 32 | AIO-Studien-gGmbHOTHER | 1 | Aug 10, 2021 | clinicaltrials |
| NCT02444572 | Comparison of Thromboembolic Events in Patients Undergoing Thromboprophylactic Treatment With ENOXA® vs Lovenox®(ENOXACARE) | completed | Phase 4 | 168 | Les Laboratoires des Médicaments StérilesINDUSTRY | 1 | Jul 29, 2021 | clinicaltrials |
| NCT03980704 | Preoperative High Protein vs Immunodiet in Surgical Cancer Patients(Preop immuno) | completed | Phase 4 | 299 | Stanley Dudrick's Memorial HospitalOTHER | 1 | Jul 26, 2021 | clinicaltrials |
| NCT00980018 | An Exploratory Trial to Assess the Improvement of Adverse Events in Chronic Myelogenous Leukemia Patients Treated With Imatinib When Switched to Nilotinib Treatment(MACS0999) | completed | Phase 4 | 52 | Novartis PharmaceuticalsINDUSTRY | 2 | Jul 1, 2021 | clinicaltrials |
| NCT02459964 | Compare Fentanyl Nasal Spray With Intravenous Opioids to Treat Severe Pain | completed | Phase 4 | 84 | M.D. Anderson Cancer CenterOTHER | 1 | Jun 16, 2021 | clinicaltrials |
| NCT03511378 | Immunogenicity Assessment of Peg-filgrastim vs. Neulasta® as Adjunct to Chemotherapy in Patients With Breast Cancer | completed | Phase 4 | 138 | Lupin Ltd.INDUSTRY | 1 | Jun 15, 2021 | clinicaltrials |
| NCT00847912 | CSP #562 - The VA Keratinocyte Carcinoma Chemoprevention Trial(VAKCCT) | completed | Phase 4 | 954 | VA Office of Research and DevelopmentFED | 1 | Jun 11, 2021 | clinicaltrials |
| NCT01789281 | Everolimus Roll-over Protocol for Patients Who Have Completed a Previous Novartis-sponsored Everolimus Study. | completed | Phase 4 | 34 | Novartis PharmaceuticalsINDUSTRY | 9 | Jun 11, 2021 | clinicaltrials |
| NCT00688909 | Rheumatological Evaluation of Anastrozole and Letrozole as Adjuvant Treatment in Post-menopausal Women With Breast Cancer(REAL) | completed | Phase 4 | 261 | Novartis PharmaceuticalsINDUSTRY | 1 | Jun 9, 2021 | clinicaltrials |
| NCT00414765 | Aldesleukin in Participants With Metastatic Renal Cell Carcinoma or Metastatic Melanoma | completed | Phase 4 | 26 | Novartis PharmaceuticalsINDUSTRY | 1 | Jun 8, 2021 | clinicaltrials |
| NCT03853551 | Osimertinib Study in Indian Patients | completed | Phase 4 | 60 | AstraZenecaINDUSTRY | 1 | Jun 3, 2021 | clinicaltrials |
| NCT00622505 | Zoledronic Acid Treatment (Every 4 or 12 Weeks) to Prevent Skeletal Complications in Advanced Multiple Myeloma Participants(Z-MARK) | completed | Phase 4 | 121 | Novartis PharmaceuticalsINDUSTRY | 1 | May 26, 2021 | clinicaltrials |
| NCT03607149 | Pemetrexed in Maintenance in Patients With Impaired Renal Function, 2 Dose Calculation Strategies(PKAPIR) | completed | Phase 4 | 11 | Centre Georges Francois LeclercOTHER | 1 | May 24, 2021 | clinicaltrials |
| NCT01953107 | Oral Iron vs. Placebo in Newly Diagnosed Gynecologic Oncology Patients Who Are Surgical Candidates. | completed | Phase 4 | 200 | Sunnybrook Health Sciences CentreOTHER | 1 | May 12, 2021 | clinicaltrials |
| NCT03469310 | Minimizing Narcotic Analgesics After Endocrine Surgery | completed | Phase 4 | 126 | Minerva A Romero ArenasOTHER | 1 | May 11, 2021 | clinicaltrials |
| NCT02472249 | Pharmacological Manipulation of Intrahepatic Arterial Blood Flow in HCC | completed | Phase 4 | 10 | University Health Network, TorontoOTHER | 1 | Apr 28, 2021 | clinicaltrials |
| NCT04162834 | Effect of Papaverine on Renal Artery Blood Flow Volume | completed | Phase 4 | 96 | Asan Medical CenterOTHER | 1 | Apr 19, 2021 | clinicaltrials |
| NCT01990534 | A Study of Brentuximab Vedotin in Participants With Relapsed or Refractory Hodgkin Lymphoma | completed | Phase 4 | 60 | Millennium Pharmaceuticals, Inc.INDUSTRY | 7 | Apr 9, 2021 | clinicaltrials |
| NCT03607227 | Continous Popliteal Block for Microvascular Free Flap Reconstruction in Ear, Nose and Throat Surgery | completed | Phase 4 | 24 | Region SkaneOTHER | 1 | Apr 8, 2021 | clinicaltrials |
| NCT04209933 | Helicobacter Pylori Eradication With Different Bismuth Quadruple Therapies | completed | Phase 4 | 240 | Xijing Hospital of Digestive DiseasesOTHER | 1 | Apr 8, 2021 | clinicaltrials |
| NCT04832906 | UA Versus UAE in Treatment of Fibroids | completed | Phase 4 | 70 | Ain Shams Maternity HospitalOTHER | 1 | Apr 6, 2021 | clinicaltrials |
| NCT03063255 | Comparison of Obturator Nerve Blockade and Neuromuscular Blockade | completed | Phase 4 | 60 | University of FloridaOTHER | 1 | Mar 24, 2021 | clinicaltrials |
| NCT03630198 | Pain Outcomes Following Intralesional Corticosteroid Injections | completed | Phase 4 | 31 | Vanderbilt University Medical CenterOTHER | 1 | Mar 11, 2021 | clinicaltrials |
| NCT02087384 | HPV (Human Papilloma Virus) Vaccination After Treatment of Anal Intraepithelial Neoplasia (AIN)(VACCAIN-P) | completed | Phase 4 | 126 | Prof. Jan PrinsOTHER | 1 | Mar 5, 2021 | clinicaltrials |
| NCT03038152 | Magseed Magnetic Marker in Locating Axillary Lymph Nodes in Patients With Breast Cancer Undergoing Surgery | completed | Phase 4 | 54 | M.D. Anderson Cancer CenterOTHER | 1 | Mar 5, 2021 | clinicaltrials |
| NCT02864030 | PAINTER: Polymorphism And INcidence of Toxicity in ERibulin Treatment | completed | Phase 4 | 200 | Oncologia Medica dell'Ospedale FatebenefratelliOTHER_GOV | 1 | Mar 4, 2021 | clinicaltrials |
| NCT04607525 | Dexmedetomidine Infusion Effect on Hemodynamic Variables During Craniotomy | completed | Phase 4 | 40 | Ain Shams UniversityOTHER | 1 | Mar 1, 2021 | clinicaltrials |
| NCT03723447 | Intraoperative TAP Block With Bupivacaine/Dexamethasone Against Liposomal Bupivacaine (Exparel®)(TINGLE) | completed | Phase 4 | 102 | Cedars-Sinai Medical CenterOTHER | 1 | Feb 17, 2021 | clinicaltrials |
| NCT02624349 | Immunogenicity and Safety of Human Papilloma Virus Vaccine in Solid Organ Transplant Recipients | completed | Phase 4 | 37 | The Hospital for Sick ChildrenOTHER | 1 | Feb 15, 2021 | clinicaltrials |
| NCT04707547 | Immune Profile and Prognosis of Malignant Liver Tumors With Radiofrequency Ablation (RFA) Therapy(RFA) | completed | Phase 4 | 5 | Taipei Medical University WanFang HospitalOTHER | 1 | Jan 13, 2021 | clinicaltrials |
| NCT02052557 | The Effect of Exparel on Post Operative Pain and Narcotic Use After Colon Surgery | completed | Phase 4 | 51 | Des Moines UniversityOTHER | 1 | Jan 8, 2021 | clinicaltrials |
| NCT01739764 | An Extension (Rollover) Study of Vemurafenib in Participants With BRAF V600 Mutation-Positive Malignancies Previously Enrolled in an Antecedent Vemurafenib Protocol | completed | Phase 4 | 215 | Hoffmann-La RocheINDUSTRY | 25 | Jan 7, 2021 | clinicaltrials |
| NCT01101750 | Does the HPV Vaccine Cause the Same Response in Adolescent Kidney and Liver Transplant Patients as in Healthy Controls? | completed | Phase 4 | 25 | Medstar Health Research InstituteOTHER | 1 | Jan 5, 2021 | clinicaltrials |
| NCT01753297 | A Study of Immediate 9 Months Adjuvant Hormone Therapy With Triptorelin 11.25 mg Versus Active Surveillance After Radical Prostatectomy in High Risk Prostate Cancer Patients.(PRIORITI) | completed | Phase 4 | 226 | IpsenINDUSTRY | 2 | Dec 9, 2020 | clinicaltrials |
| NCT03444766 | Study of Nivolumab for Advanced Cancers in India | completed | Phase 4 | 100 | Bristol-Myers SquibbINDUSTRY | 1 | Dec 4, 2020 | clinicaltrials |
| NCT02721433 | 4-weekly Versus 12-weekly Administration of Bone-targeted Agents in Patients With Bone Metastases(REaCT-BTA) | completed | Phase 4 | 263 | Ottawa Hospital Research InstituteOTHER | 1 | Dec 2, 2020 | clinicaltrials |
| NCT03176849 | A Randomized Phase IV Control Trial of Single High Dose Oral Vitamin D3 in Pediatric Patients Undergoing HSCT | completed | Phase 4 | 49 | Phoenix Children's HospitalOTHER | 1 | Nov 17, 2020 | clinicaltrials |
| NCT00395863 | Multihance at 3 Tesla (3T) in Brain Tumors | completed | Phase 4 | 46 | Bracco Diagnostics, IncINDUSTRY | 1 | Nov 5, 2020 | clinicaltrials |
| NCT01588184 | An Extension Study to Provide Continued Bevacizumab Therapy to Participants With Solid Tumors Who Were Previously Enrolled in a Roche/Genentech Sponsored Study | completed | Phase 4 | 95 | Hoffmann-La RocheINDUSTRY | 21 | Nov 5, 2020 | clinicaltrials |
| NCT04009941 | Efficacy and Safety of 4.5mg PEG-rhG-CSF Per Cycle in Preventing Neutropenia After Intensive Chemotherapy for Breast Cancer | completed | Phase 4 | 104 | Peking UniversityOTHER | 1 | Oct 28, 2020 | clinicaltrials |
| NCT03007225 | Efficacy and Safety of Drug Eluting Beads TACE in Treatment of HCC in Egyptian Patients | completed | Phase 4 | 50 | Ain Shams UniversityOTHER | 0 | Oct 22, 2020 | clinicaltrials |
| NCT01856803 | Anti-thymocyte Globulins for Graft-versus-host Disease Prophylaxis | completed | Phase 4 | 300 | Peking University People's HospitalOTHER | 1 | Sep 25, 2020 | clinicaltrials |
| NCT01199198 | Tolvaptan in Hyponatremic Cancer Patients | completed | Phase 4 | 52 | M.D. Anderson Cancer CenterOTHER | 1 | Sep 23, 2020 | clinicaltrials |
| NCT03138967 | Investigation of Sugammadex in Outpatient Urological Procedures | completed | Phase 4 | 54 | M.D. Anderson Cancer CenterOTHER | 1 | Sep 22, 2020 | clinicaltrials |
| NCT03397914 | Effect of Different Colistin Doses on Clinical Outcome of Pediatric Cancer Patients With Gram Negative Infections | completed | Phase 4 | 70 | National Cancer Institute, EgyptOTHER | 1 | Sep 16, 2020 | clinicaltrials |
| NCT02502864 | Multicenter Study of Pharmacokinetic-Guided Docetaxel in Breast Cancer Patients Receiving Docetaxel and Cyclophosphamide | completed | Phase 4 | 9 | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 1 | Sep 11, 2020 | clinicaltrials |
| NCT00510354 | Treatment of Patients With Everolimus and Imatinib Mesylate Who Have Progressive Gastro Intestinal Stromal Tumors (GIST) and Are Resistant to Imatinib Mesylate(Radix) | completed | Phase 4 | 28 | Novartis PharmaceuticalsINDUSTRY | 1 | Sep 10, 2020 | clinicaltrials |
Data updated 23 days agoSource updated Aug 25, 2021source: clinicaltrials